Company intelligence / Profile preview

Rinicare

Alderley Park / Manchester, England, United Kingdomventureradar.com ↗

Ownership: Private
Development stage: Other

Overview

Rinicare has commercialized its SAFE falls prevention device and PRIME IoT remote vital sign monitor. Its STABILITY AI-based clinical deterioration prediction tool has captured data from thousands of ICU patients but remains under further development. The company’s products are used to improve outcomes and reduce costs across emergency, primary, community, hospital, and intensive care settings.

Therapeutic areas: Other
Modalities: Device (for falls prevention and vital sign monitoring)Software (AI-powered predictive analytics)Digital health platform
Industry: Digital Health Medical Devices

Partnerships

University Hospital of South Manchester

Beyond the preview

Go deeper on Rinicare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rinicare.

Explore the full profile